MTEM Insider Trading Activity and SEC Form 4 Filings
MTEM insider trading summary
No open-market insider purchases or sales of Molecular Templates, Inc. (MTEM) have been reported on SEC Form 4 in the past 12 months.
Latest MTEM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 14, 2024 | Biotech AG Bb | Insider | Sell | $846K (1,279,820 @ $0.66) |
| Nov 14, 2024 | Target N V Biotech | Insider | Sell | $846K (1,279,820 @ $0.66) |
| Apr 2, 2024 | Biotech AG Bb | Insider | Buy | $588K (250,000 @ $2.35) |
| Apr 2, 2024 | Target N V Biotech | Insider | Buy | $588K (250,000 @ $2.35) |
| Jul 17, 2023 | Target N V Biotech | Insider | Buy | $2.0M (4,255,319 @ $0.47) |
| Jul 17, 2023 | Biotech AG Bb | Insider | Buy | $2.0M (4,255,319 @ $0.47) |
| Jun 16, 2022 | Sean McLennan | See remarks | Buy | $24K (30,000 @ $0.82) |
| Jun 15, 2022 | Sante Health Ventures I Annex Fund, LP | 10% Owner | Buy | $55K (62,000 @ $0.89) |
| Jun 15, 2022 | SHV Annex Services, LP | 10% Owner | Buy | $55K (62,000 @ $0.89) |
| Jun 15, 2022 | SHV Management Services, LP | 10% Owner | Buy | $55K (62,000 @ $0.89) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.